Corrigendum to "Dual-targeting liposomal delivery of sorafenib and docetaxel for enhanced synergistic therapy in advanced hepatocellular carcinoma" [Pharmaceut. Sci. Adv. 2 (2024) 100046].

Authors

Yawen Yao, Yue Hu, Xinwang Meng, Fenyan Feng, Feng Xu, Guangji Wang, Hua Yu, Juan Li

Published in

Pharmaceutical science advances. Volume 4. Pages 100145. Epub Oct 08, 2026.

Abstract

[This corrects the article DOI: 10.1016/j.pscia.2024.100046.].

PMID:
42898070
Bibliographic data and abstract were imported from PubMed on 20 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.